Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Stavzor valproic acid regulatory update

FDA granted tentative approval to an NDA from Noven for Stavzor valproic acid

Read the full 130 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE